Luke Buizen

The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy Study

Jason A. Roberts, Gavin M. Joynt, Anna Lee et al. · Clinical Infectious Diseases · 2020 · 130 citations · Full text

Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study

Boris Waldman, Jean-Claude Ansquer, David Sullivan et al. · The Lancet Diabetes & Endocrinology · 2018 · 57 citations

Metabolic Syndrome, Diabetes Management, Field Study +10

A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis

Glen Kennedy, Siok‐Keen Tey, Luke Buizen et al. · Blood · 2021 · 48 citations · Full text

Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) – Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS)

Felicia Roncolato, Dominique Berton-Rigaud, Rachel O’Connell et al. · Gynecologic Oncology · 2017 · 37 citations

Prognostic Evaluation, Prognostic Biomarkers, Medicine +9

Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer—The GCIG Symptom Benefit Study

Felicia Roncolato, Florence Joly, Rachel O’Connell et al. · The Oncologist · 2017 · 25 citations · Full text